Compass Financial Management’s Oruka Therapeutics ORKA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-38
Closed -$3.73K – 1802
2026
Q2
$3.73K Buy
+38
New +$2.53K ﹤0.01% 1238

Other funds holding ORKA

Compass Financial Management's ORKA Position: Q3 2026 in Review

Compass Financial Management sold out of Oruka Therapeutics (ORKA) in Q3 2026, closing a stake of 38 shares — an estimated $3.73K sold.

Compass Financial Management first reported a position in ORKA in Q2 2026 and held it in 1 quarter. The position peaked at $3.73K in Q2 2026. 259 funds tracked by Wall St. Rank hold ORKA as of Q3 2026.

  • Compass Financial Management reported no remaining Oruka Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Compass Financial Management sold 38 Oruka Therapeutics shares in Q3 2026, an estimated $3.73K.
  • Compass Financial Management first reported a position in Oruka Therapeutics in Q2 2026 and held it in 1 quarter.
  • Compass Financial Management's Oruka Therapeutics position peaked at $3.73K in Q2 2026.
  • 259 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q3 2026.

Based on Compass Financial Management's 13F filing for Q3 2026, filed 30 Oct 2026.